10000 to 4crs in 18 months 1000rs to 50crs 300% returns 75% promoter holdings A 50 bagger A sureshot 5 bagger Analysis Another fraud? Auto ancillaries Bank sector Blind sell Brand plays Broking Bse Nse Buy calls cements Ceramics/tiles Counters I don't like Debt free businesses Delisting candidates demerger bets Disclosure- I own them Domestic consumption plays E-Commerce pick Education Exit at rallies Famous analysts Famous stocks FMCG Footwear future multibaggers Gems andJewellery Hidden gems High conviction ideas High dividend plays High potential small caps High ROE stocks Holding companies Hotel sector How they looted you.. Indian stock market Infrastructure sector Interesting Microcaps IT KPO Landbank plays largecap ideas Less than 5 PE stocks Liquor Logistics Market lessons Market outlook for 2013 and 2014 Market underperformers Meeting with the CEO Metals Monopoly businesses My 5 baggers My Favourite counters My paid stock recommendations My stock picking techniques nse bse tips Oil exploration Operator calls Paints Penny stock outlook penny stock updates Pharma sector Poultry stocks PSU Publicity freaks Real estate Renewable energy plays Safe bets Sell recommendations Share market Live shipping stocks short term call SOTP plays stock tips stock under 10rs Stocks to watch out for Strong bonus candidates Takeover candidates TATA product tea Textiles The 13 bagger The 45 bagger Trading companies Transformers Turnaround bets Tyres Uncertain/Risky business models Unique businesses

Search This Blog(Over 800 companies covered in the blog).

Archives : Old artciles

Monday, January 11, 2010

Celestial Biolabs Ltd:Buy/sell/hold,growth prospects and recomendation,news and results,target price and analysis,views and outlook

Scripscan:Celestial Biolabs Ltd

Story:Celestial Labs Limited develops biopharmaceuticals and industrial enzymes. It also provides enterprise resource planning solutions, data warehousing, business intelligence solutions, Web application development, and products and tools for information technology; and bio services, such as clinical data management, gene sequence analysis, molecular modeling, and design and development of drug molecules. The company’s bio-informatics products include CELSUITE, an integrated and customized software toolkit that generates lead molecules based on the target structure and predicts the potential toxicity in the initial stages of drug discovery; and PDC Database, a database of plants, human diseases, and bioactive compounds. It is also developing two molecules to treat leucoderma/vitiligo, tanning, wrinkles, and multiple cancers. In addition, the company involves in developing technological base for the production of industrial enzymes that include Alpha Amylase and Alkaline Protease for detergents, textiles, food, and pharmaceutical industries. Celestial Labs offers its solutions and services to government institutions, pharma and biotech companies, hospitals, and medical centers in India and internationally. It has technology alliances with Institute of Microbial Technology and Osmania University in IndiaCelestial Labs is a combination of a technology and a pharmaceutical company. They have bioinformatics, enterprise resource planning (ERP) and molecule development software for the pharma companies. They are also into herbal and allopathic products. So it’s a combination of these two.We expect earnings per share (EPS) of around Rs 10 for this year. Next year it could be Rs 13-14. These are companies, which are trying to put their act in place. That’s the biggest risk.We could see levels of around Rs 60-70 but at least a short to medium-term target is around Rs 40-45.


Important Disclaimer&Privacy policy

This blog does not share personal information with third parties nor do we store any information about your visit to this blog other than to analyze and optimize your content and reading experience through the use of cookies.You can turn off the use of cookies at anytime by changing your specific browser settings.This privacy policy is subject to change without notice and was last updated on 20.3.2013. If you have any questions, feel free to contact me directly here: Investment in equity shares has its own risks.Sincere efforts have been made to present the right investment perspective.The information contained herein is based on analysis and up on sources that I consider reliable. I,however,do not vouch for the accuracy or the completeness thereof.This material is for personal information and am not responsible for any loss incurred based upon it & take no responsibility whatsoever for any financial profits or loss which may arise from the recommendations above.The stock price projections shown are not necessarily indicative of future price performance.The information herein, together with all estimates and forecasts, can change without notice.

Subscription to Arunthestocksguru

Enter your email address:

Delivered by FeedBurner